Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Apoorva Jayarangaia"'
Autor:
Pramod Theetha Kariyanna, Ashish Kumar, Amog Jayarangaiah, Mrinali Shetty, Yuvraj Chowdhury, Sushruth Das, Apoorva Jayarangaiah
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundLeft ventricular dysfunction and cardiomyopathy are well documented adverse effects associated with chemotherapy agents. Limited information exists regarding the impact of chemotherapeutic agents on the integrity and function of the right v
Externí odkaz:
https://doaj.org/article/dcd2d350b22b45f482ee42bd21bf0ee6
Autor:
Pramod Theetha Kariyanna, Parth Shah, Apoorva Jayarangaiah, Yuvraj Singh Chowdhury, Deana Lazaro
Publikováno v:
European Journal of Rheumatology, Vol 8, Iss 1, Pp 31-35 (2021)
Externí odkaz:
https://doaj.org/article/e549fdf8a52d42e097d4136e51a2060b
Autor:
Shuai Wang, Apoorva Jayarangaiah, Mariuxi Malone, Tarek Elrafei, Lewis Steinberg, Abhishek Kumar
Publikováno v:
EClinicalMedicine, Vol 28, Iss , Pp 100601- (2020)
Background: Mogamulizumab (Moga) is a CC chemokine receptor-4 antibody approved in the United States for relapsed /refractory mycosis fungoides and Sézary syndrome. Few cases reported an increased risk of hepatitis B reactivation and cytomegalovi
Externí odkaz:
https://doaj.org/article/35e9c7adcd8940cbbb48434ac19b72aa
Autor:
Apoorva Jayarangaiah MD, Pramod Theetha Kariyanna MD, Xiaoyi Chen MD, Amog Jayarangaiah MD, Abhishek Kumar MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Since the onset of the global pandemic in early 2020, coronavirus disease 2019 (COVID-19) has posed a multitude of challenges to health care systems worldwide. In order to combat these challenges and devise appropriate therapeutic strategies, it beco
Externí odkaz:
https://doaj.org/article/8a10b5ffc806486fbce7ad85a9215361
Autor:
Apoorva Jayarangaia, Benjamin Ramalanjaona, Denis Yusupov, Mohammed Al-Sadawi, Pramod Theetha Kariyanna, Isabel M. McFarlane
Publikováno v:
American journal of medical case reports
Patients with human immunodeficiency virus (HIV) are at higher risk for coronary artery disease, due to accelerated atherosclerosis resulting from chronic inflammation, the prevalence of cardiovascular risk factors and the side effects of highly acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8091b45a1bad20c313393251d97ffdf0
https://pubmed.ncbi.nlm.nih.gov/31552289
https://pubmed.ncbi.nlm.nih.gov/31552289